Home
Conditions
Histiocytosis

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

396 public trials 79 recruiting studies

Refine in advanced search Browse all conditions

Histiocytosis trial results

Not Yet Recruiting

Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis

NCT06951971

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis (HLH), Histiocytosis, +3 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

AZA Combined with R-GemOx for Elderly DLBCL Patients

NCT06778902

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +12 more
Locations: Daping Hospital, Third Military Medical University (Army Medical University) Chongqing, China

View Trial Details

Not Yet Recruiting

The Microbiome in Blood Cancer and HLH

NCT06734624

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Haemophagocytic Lymphohistiocytosis, +15 more
Locations: University of Nottingham Nottingham, Nottinghamshire, United Kingdom

View Trial Details

Not Yet Recruiting

Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis

NCT06504030

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

NCT06131489

Conditions: Bowel Resection, DNA Virus Infections, Epstein-Barr Virus, +11 more
Locations: Zhao Wang Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections

NCT05988177

Conditions: Carbapenem Resistant Bacterial Infection, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, +4 more
Locations: Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

NCT05775705

Conditions: DNA Virus Infections, Epstein-Barr Virus, Epstein-Barr Virus Infections, +17 more
Locations: Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Completed

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT04113226

Conditions: Chemotherapy, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-Cell Lymphoma (DLBCL), Nos, +18 more
Locations: CHU Amiens Amiens, France

View Trial Details

Completed

Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life

NCT06026644

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Aou Di Bologna - Policlinico S. Orsola-malpighi - Uoc Ematologia Bologna, Italy

Asst Degli Spedali Civili Di Brescia - Ssvd Centro Trapianti Midollo Per Adulti - Cattedra Di Ematologia Brescia, Italy

AOU Careggi - SOD terapie cellulari e Medicina Trasfusionale Florence, Italy

Irccs Aou San Martino - Genova - Uo Ematologia E Trapianti Genova, Italy

View all 13 locations

View Trial Details

Completed

Functional Near-Infrared Spectroscopy (fNIRS) Combined With Diffuse Correlation Spectroscopy (DCS) in Neurocognitive Disease as Compared to Healthy Neurotypical Controls

NCT05642221

Conditions: Abnormalities, Multiple, Brain Diseases, Brain Diseases, Metabolic, +33 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Histiocytosis

Histiocytosis trial results

Related conditions